Rejection in Academia: A Door Open or a Door Closed?

James Quinn, PhD, is a researcher in the Alzheimer's Clinical and Translational Research Unit (ACTRU) studying the mechanisms underlying dementia development to identify new biomarkers and novel therapeutic targets, focusing on the signaling molecules, neuropeptides. Outside the lab, James is an avid science communicator, rock climber and live music enthusiast. [rd_line color="#00a9ce" line_pos="center" margin_top="15" margin_bottom="15"]…Read More